F-PV9 is a novel synthetic cathinone compound that is also known as 4-fluoro-α-Pyrrolidinopentiothiophenone. It belongs to the class of cathinone derivatives, which are synthetic substances that mimic the effects of cathinone, a psychoactive substance found in the khat plant. F-PV9 is a relatively new compound and its effects on humans have not been extensively studied.
F-PV9 has a molecular formula of C15H20FNO2S and a molecular weight of 307.39 g/mol. It has a melting point of 98-99°C and a boiling point of 435.2°C at 760 mmHg. The compound has a white or off-white crystalline appearance and is usually sold as a powder or in tablet form.
F-PV9 can be synthesized from α-Pyrrolidinopentiothiophenone (α-PVP) and 4-fluorobenzaldehyde. The synthesis process involves a reaction between these two compounds using acetic acid as a solvent. The resulting product is then purified and crystallized to obtain F-PV9.
F-PV9 is a stimulant drug that acts on the central nervous system by increasing the levels of dopamine, norepinephrine, and serotonin in the brain. It is believed to work by inhibiting the reuptake of these neurotransmitters, leading to increased levels of these chemicals in the brain. F-PV9 is also known to have a high binding affinity for the serotonin transporter.
Effects on the Body
The effects of F-PV9 on the body can vary depending on the dose, route of administration, and individual factors such as age, weight, and tolerance. However, some of the common effects of the drug include:
- Euphoria and feelings of well-being
- Increased sociability and talkativeness
- Increased energy and alertness
- Enhanced sensory perception
- Reduced appetite and thirst
- Increased heart rate and blood pressure
- Dilated pupils
- Increased body temperature
- Agitation and anxiety
Side Effects and Risks
Like other cathinone derivatives, F-PV9 has the potential to cause a range of side effects and health risks, especially with long-term use or at high doses. Some of the side effects that have been reported include:
- Headaches and dizziness
- Nausea and vomiting
- Confusion and disorientation
- Paranoia and hallucinations
- Chest pain and heart palpitations
- Difficulty breathing
- Organ damage and failure
- Addiction and dependence
F-PV9 is a controlled substance in many countries, including Sweden, where it is classified as a Schedule I drug under the Act on Control of Certain New Psychoactive Substances.